Login to Your Account

Financings Roundup

Aerovance Clears $38M Round Despite Tightening Economy

By Jennifer Boggs

Tuesday, April 7, 2009
When Aerovance Inc. decided last year to put off partnering plans for its Aerovant inhaled asthma program until after Phase IIb - with the goal of building up value for a better deal - the firm could not foresee the market's stunning decline in the latter part of 2008 that would make raising venture capital money a challenging prospect. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription